• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec26
Genmab and BioNTech terminate GEN1055 cancer trial
16:32
Dec19
Bristol Myers Squibb and BioNTech Announce Progress in ROSETTA RCC-208 Study
16:33
Dec18
BioNTech Completes Acquisition of CureVac to Enhance mRNA Capabilities
09:45
Dec12
Berenberg Raises BioNTech's Target Price to $155
07:16
Dec10
Citi Analyst Maintains Buy Rating on BioNTech SE
10:26
BioNTech Maintains Strong Buy Rating on Positive Lung Cancer Phase III Data
02:36

Schedules & Filings

Schedules
Filings
Nov3
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.781 B, Net Income -33.66 M, EPS -0.1407

BioNTech SE (BNTX.US) Q3 2025 Earnings Conference CallBioNTech SE (BNTX.US) Q3 2025 Earnings Conference Call
Aug4
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 305.28 M, Net Income -452.53 M, EPS -1.8728

BioNTech SE (BNTX.US) Q2 2025 Earnings Conference CallBioNTech SE (BNTX.US) Q2 2025 Earnings Conference Call
May5
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 197.88 M, Net Income -450.1 M, EPS -1.8726

BioNTech SE (BNTX.US) Q1 2025 Earnings Conference CallBioNTech SE (BNTX.US) Q1 2025 Earnings Conference Call
View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
EKSO
10.580
+93.77%
+5.120
AEHL
2.180
+92.92%
+1.050
AFJK
82.580
+89.19%
+38.930
PFSA
0.1218
+78.33%
+0.053
DLXY
1.410
+67.86%
+0.570
ULY
2.760
+52.49%
+0.950
MENS
4.220
+51.80%
+1.440
CETX
2.980
+41.23%
+0.870
DAIC
0.5500
+39.06%
+0.154
ONTF
8.060
+37.54%
+2.200
View More